Boill Healthcare Outlines Board and Committee Structure

An update from Boill Healthcare Holdings Limited ( (HK:1246) ) is now available.

Boill Healthcare Holdings Limited has announced the current composition of its board of directors, led by chairman and executive director Zhuo Wenjie, alongside two other executive directors, one non-executive director and three independent non-executive directors. The company has also detailed the membership and chairmanship of its three key board committees—Audit, Nomination and Remuneration—highlighting the central role of its independent directors in overseeing governance and aligning with Hong Kong listing requirements.

Independent non-executive director Yau Yan Yuen chairs the Audit Committee and serves on the Nomination and Remuneration Committees, while fellow independent director Xiao Lihong chairs the Remuneration Committee and sits on the Audit and Nomination bodies. The third independent director, Liang Yanan, chairs the Nomination Committee and is a member of both the Audit and Remuneration Committees, underscoring a governance framework that concentrates committee oversight in the hands of independent board members.

More about Boill Healthcare Holdings Limited

Boill Healthcare Holdings Limited, incorporated in the Cayman Islands and listed in Hong Kong under stock code 1246, operates in the healthcare sector. The company is overseen by a board comprising executive, non-executive and independent non-executive directors, reflecting a typical governance structure for a listed healthcare group.

Technical Sentiment Signal: Sell

Current Market Cap: HK$28.52M

Find detailed analytics on 1246 stock on TipRanks’ Stock Analysis page.